Trial Profile
Phase II study of AST 915 for treatment of essential tremor.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2011
Price :
$35
*
At a glance
- Drugs AST 915 (Primary)
- Indications Essential tremor
- Focus Therapeutic Use
- 04 Feb 2011 New trial record